Showing 341 - 360 of 530 results
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.
Researchers from UNSW have found an extraordinary material that does expand or contract over an extremely wide temperature range and may be one of the most stable materials known.
ANSTO has hosted its second IAEA Practical Introduction to Nuclear Forensics Regional Training Course for representatives of member countries from South-East Asia, sharing expertise on the theoretical and practical aspects of nuclear forensics to respond to incidents of nuclear or other radioactive material out of regulatory control.
ANSTO has put together a robust multidisciplinary approach to understanding the impacts of nanomaterials, investigating a common food additive, E171 titanium dioxide, used primarily as a colouring agent in everyday foods.
Study explored how key proteins manage dietary cholesterol absorption and elucidated crucial transport mechanisms that contribute to cholesterol balance in the body.
Historic memorandums of understanding on the peaceful use of nuclear with Thailand and Canada.
Radioisotope tracing technique are used to understand the uptake of contaminants, and nutrients, bioaccumulation, by aquatic organisms and terrestrial plants.
The growth and incorporation of graphene into semiconductor device architectures has been limited by challenges related to the quality, reproducibility, and high process temperatures required to grow it on suitable substrates.
With over 70 years of nuclear expertise, ANSTO offers expert education and training programs
Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia
ANSTO proudly contributes to measures that recognise all aspects of Aboriginal and Torres Strait Islander culture and heritage during NAIDOC Week and all year.
Nuclear security experts and officials from Australia’s nuclear agencies have convened at the International Atomic Energy Agency’s (IAEA) headquarters in Vienna, Austria last week for the International Conference on Nuclear Security (ICONS).
ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.
Research confirms that fraudulent Kakadu plum extracts are in circulation online and in the international marketplace.